Skip to content

Microcirculatory Guided Goal Directed Fluid Therapy in Septic Shock; a Feasibility Study

Microcirculatory Guided Goal Directed Fluid Therapy in Septic Shock; a Feasibility Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03898674
Acronym
MICRORESUS
Enrollment
30
Registered
2019-04-02
Start date
2019-02-05
Completion date
2020-10-01
Last updated
2019-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock

Brief summary

Prospective single centre study to assess the feasibility of fluid resuscitation guided by macrocirculatory and microcirculation parameters in patients in the early stages of septic shock. The investigators will utilise a novel point of care tool to assess microcirculatory sublingual perfusion in patients with septic shock. This, in combination with conventional haemodynamic monitoring will determine the timing and volume of resuscitative fluid administration. The feasibility of this technique will be determined prior to embarking on a pilot RCT.

Interventions

DRUGIntra venous fluid

Volume of intra venous fluid administered during GDT protocol

Sponsors

King's College London
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Feasibility study - single arm

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Age \> 18 years Within 6 hours of ICU admission Evidence of suspected or confirmed infection Serial Organ Failure Assessment (SOFA) score increase of 2 or more (assuming baseline 0 if no previous measures) Requiring vasopressor therapy to maintain a MAP \> 65mmHg Lactate \> 2 mmol/l despite initial fluid resuscitation Requirement for advanced haemodynamic monitoring (PiCCO system) in the opinion of the attending clinician

Exclusion criteria

Patients not expected to survive 24 h in whom the intent of treatment is palliative Patients in whom the primary cause of the shock state is cardiogenic \-

Design outcomes

Primary

MeasureTime frameDescription
Time to acquire POEM score6 hoursFeasibility measure of point of care test
Effect of POEM score on clinical decision making6 hoursFeasibility outcome measure

Countries

United Kingdom

Contacts

Primary ContactSam Hutchings, PhD
sam.hutchings@nhs.net07832678654

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026